While others have reported on the significant MACE reduction with GLP-1RA therapy in the secondary prevention cohort, but not in the primary prevention setting [91], our findings extend the current notion that the beneficial impact on the individual MACE constituents, particularly MI risk reduction, may be attenuated in the higher risk secondary preventative population with established CVD, often characterized by advanced age and multimorbidity status [90]
This tripeptide is naturally produced in our cells but can be depleted by factors like stress , pollution , poor diet , and aging
Lee YH, Layman DK, Bell RR
Its a paradigm shift that were thinking of obesity not as a failure on the patients part to control their habits, but more of a chronic disease, and treating it like any other chronic disease such as diabetes or high blood pressure, arthritis, or other diseases that people readily will say is not the patients fault, Dr